Magnum - Relationships built on growth

SENSEX

{{sensexData[0].price}} (+{{sensexData[0].change}}%)
SENSEX

{{sensexData[0].price}} ({{sensexData[0].change}}%)
NIFTY 50

{{niftyData[0].open_price}} (+{{niftyData[0].change}}%)
NIFTY 50

{{niftyData[0].open_price}} ({{niftyData[0].change}}%)
{{mcxData[2].symbol}}

{{mcxData[2].price}} (+{{mcxData[2].PerChange}}%)
{{mcxData[2].symbol}}

{{mcxData[2].price}} ({{mcxData[2].PerChange}}%)
{{mcxData[0].symbol}}

{{mcxData[0].price}} (+{{mcxData[0].PerChange}}%)
{{mcxData[0].symbol}}

{{mcxData[0].price}} ({{mcxData[0].PerChange}}%)
{{mcxData[1].symbol}}

{{mcxData[1].price}} (+{{mcxData[1].PerChange}}%)
{{mcxData[1].symbol}}

{{mcxData[1].price}} ({{mcxData[1].PerChange}}%)
{{mcxData[3].symbol}}

{{mcxData[3].price}} (+{{mcxData[3].PerChange}}%)
{{mcxData[3].symbol}}

{{mcxData[3].price}} ({{mcxData[3].PerChange}}%)

Manipal Health Enterprises Ltd	Back
Registered Office: The Annexe #98/2 Rustom Bagh,Hal Airport Road, Bangalore - 560017, Karnataka, India. Phone : +91 80 4936 0300 Fax: Email : Website :
Initial public offer of up to 15,72,07,054 equity shares of face value of Rs. 2 each ("Equity Shares") of Manipal Health Enterprises Limited ("Company" or "Issuer") for cash at a price of Rs. 560-590 per equity share (including a share premium of Rs.558-588 per equity share) ("offer price") aggregating up to Rs. 9275.22 Crores comprising a fresh issue of up to 135,593,220 equity shares of face value of Rs. 2 each aggregating up to Rs. 8000.00 Crores by the company ("Fresh Issue") and an offer for sale of up to 21,613,834 equity shares of face value of Rs. 2 each aggregating up to Rs. 1275.22 Crores by the selling shareholders, comprising an offer for sale of up to 10,808,861 equity shares of face value of Rs. 2 each aggregating up to Rs. 637.72 Crores by Imperius Healthcare Investments Pte. Ltd., (the "Promoter Selling Shareholder"), up to 6,792,002 equity shares of face value of Rs. 2 each aggregating up to Rs. 400.73 Crores by Manipal Education and Medical Group India Private Limited (the "Promoter Group Selling Shareholder"), up to 2,329,667 equity shares of face value of Rs. 2 each aggregating up to Rs. 137 45 Crores by TPG SG Magazine Pte. Ltd., up to 792,494 equity shares of face value of Rs. 2 each aggregating up to Rs. 46.76 Crores by Seventy Second Investment Company LLC, up to 405,791 equity shares of face value of Rs. 2 each aggregating up to Rs. 23.94 Crores by Ammar SDN BHD, up to 264,556 equity shares of face value of Rs. 2 each aggregating up to Rs. 15.61 Crores by Novo Holdings Invest Asia A/S, and up to 220,463 equity shares of face value of Rs. 2 each aggregating up to Rs. 13.01 Crores by Phoenix Bear Investments, LLC, (collectively the "Investor Selling Shareholders") (the promoter selling shareholder, the promoter group selling shareholder and the investor selling shareholders collectively referred to as the "Selling Shareholders" and such equity shares offered by the selling shareholders ("Offered Shares") and such offer, "Offer For Sale", and together with the fresh issue, the "Offer"). This offer includes a reservation of up to 254,237 equity shares of face value of Rs. 2 each, aggregating up to Rs. 15 Crore (constituting up to []% of the post-offer paid-up equity share capital), for subscription by eligible employees (the "Employee Reservation Portion"). The company in consultation with the brlms, may offer a discount of Rs. 56 per equity share of face value of Rs. 2 each, to eligible employees bidding in the employee reservation portion ("Employee Discount"), subject to necessary approvals as may be required. The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer would constitute []% and [*]% of the post-offer paid-up equity share capital of the company, respectively. The company, in consultation with the brlms, may consider a pre-ipo placement of equity shares, as may be permitted under applicable law, at its discretion, aggregating up to Rs.1600.00 crores prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (regulation) Rules, 1957, as Amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. The utilisation of the proceeds raised pursuant to the pre-ipo placement will be done towards the proposed objects of the offer in compliance with applicable law. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). Price Band: Rs. 560 to Rs. 590 per equity share of face value of Rs. 2 each. The floor price is 280 times the face value of the equity shares and the cap price is 295 times the face value of the equity shares. Bids can be made for a minimum of 25 equity shares of face value of Rs. 2 each and in multiples of 25 equity shares of face value of Rs. 2 each thereafter. A discount of Rs. 56 per equity share is being offered to eligible employees bidding in the employee reservation portion.

Issue
Opens On	Closes On
29-Jul-26	31-Jul-26

Money Payable On
Application	Allotment
560.00	0.00

Minimum Application for shares in Nos : 25 Further Multiples of : 25
	(₹)(Cr.)	Lead Managers to the Issue
Project Cost (₹)	0.00	Axis Capital Limited
Project Financed through Current Offer (₹)	9210.37
Post Issue Equity Share Capital (₹)	267.39
Issue Price (₹)	560.00

Projects

	Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited
	Acquisition of minority stake in the company stepdown Subsidiary, Sahyadri Hospitals Private Limited
	General corporate purposes

Promoted By

	Ranjan Ramdas Pai
	Manipal Global Health Services

Listing At

	BSE
	NSE

Registrar to the Issue

KFin Techologies Ltd

Mandatory Dematerialization for Transfer of Securities, w.e.f 5th December 2018. Refer to SEBI notification number SEBI/LAD-NRO/GN/2018/24 dated June 08,2018. Update/Link your Aadhaar Number with your Demat Account by submitting a photocopy of Aadhaar card along with a request letter/Modification form. Prevent Unauthorised transactions in your account. Update your mobile numbers & email IDs with your stock brokers. Prevent unauthorized transactions in your trading account. Update your mobile numbers/email IDs with your stock brokers. Receive information/alerts of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.

Prevent Unauthorized Transactions in your demat account. Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day. Issued in the interest of investors.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment.

Filing Complaints on SCORES

Easy & quick.

Register on SCORES portal.
Provide mandatory details for filing complaints on SCORES like name, PAN, address, mobile number and email ID.
Benefits:
- Effective communication.
- Speedy redressal of grievances.

Dear Investor,

As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in the securities market.

In this connection, please visit the BSE Investor Protection Fund Website where you will find useful educational material in the form of text and videos to help you become a well-informed investor.

We believe that an educated investor is a protected investor!

Risk Disclosure on Derivatives

9 out of 10 individual traders in the Equity Futures and Options Segment incurred net losses.
On average, loss-making traders registered a net trading loss of approximately ₹50,000.
In addition to the net trading losses incurred, loss-makers spent an additional 28% of their net trading losses on transaction costs.
Traders making net profits incurred transaction costs ranging from 15% to 50% of their profits.

Source:

SEBI Study dated January 25, 2023 – Analysis of Profit and Loss of Individual Traders dealing in Equity Futures and Options (F&O) Segment

× Home Who We are Products & Services +

equity broking
derivatives broking
commodities broking
currency derivatives
Institution desk
LAS through NBFC
depository services
IPOs & NCDs
mutual funds
life & general insurance
fixed deposits & bonds
loans & finance

Markets +

Equity
Mutual Fund
Derivative
Commodity
IPO

Research Partner Us Contact Us

Filing Complaints on SCORES

Risk Disclosure on Derivatives

MAGNUM EQUITY BROKING LTD.

Registered Office